|
Kimia Biosciences Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
184.52 Cr.
|
P/BV
|
0.00
|
Book Value (Rs.)
|
0.07
|
|
52 Week High/Low (Rs.)
|
58/35
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
28/09/2020
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -1.12 | -1.98 | -0.78 | 1.08 | 0.32 |
| Diluted EPS (Rs.) | -1.12 | -1.98 | -0.78 | 1.08 | 0.28 |
| Cash EPS (Rs.) | -0.42 | -1.27 | -0.16 | 1.48 | 0.65 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 0.06 | 1.15 | 3.15 | 3.90 | 2.86 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 0.06 | 1.15 | 3.15 | 3.90 | 2.86 |
| Revenue From Operations / Share (Rs.) | 22.17 | 27.16 | 26.40 | 28.05 | 22.93 |
| PBDIT / Share (Rs.) | 0.24 | -0.79 | 0.33 | 2.29 | 1.17 |
| PBIT / Share (Rs.) | -0.45 | -1.50 | -0.29 | 1.89 | 0.81 |
| PBT / Share (Rs.) | -1.52 | -2.62 | -1.06 | 1.17 | 0.26 |
| Net Profit / Share (Rs.) | -1.12 | -1.98 | -0.78 | 1.08 | 0.29 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 1.10 | -2.92 | 1.25 | 8.16 | 5.09 |
| PBIT Margin (%) | -2.03 | -5.52 | -1.10 | 6.72 | 3.53 |
| PBT Margin (%) | -6.84 | -9.63 | -4.01 | 4.17 | 1.15 |
| Net Profit Margin (%) | -5.06 | -7.27 | -2.96 | 3.84 | 1.29 |
| Return on Networth / Equity (%) | -1603.83 | -171.19 | -24.87 | 27.68 | 10.40 |
| Return on Capital Employeed (%) | -6.98 | -15.79 | -2.88 | 16.01 | 7.98 |
| Return On Assets (%) | -5.31 | -7.70 | -3.38 | 4.78 | 1.61 |
| Long Term Debt / Equity (X) | 64.68 | 5.64 | 1.64 | 1.54 | 1.83 |
| Total Debt / Equity (X) | 131.12 | 9.69 | 2.73 | 2.25 | 2.31 |
| Asset Turnover Ratio (%) | 0.94 | 1.11 | 1.16 | 1.38 | 1.41 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 0.88 | 1.08 | 1.18 | 1.41 | 1.58 |
| Quick Ratio (X) | 0.44 | 0.45 | 0.58 | 0.94 | 1.05 |
| Inventory Turnover Ratio (X) | 1.70 | 2.50 | 3.16 | 4.69 | 4.34 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 0.22 | -0.88 | 0.42 | 3.20 | 2.14 |
| Interest Coverage Ratio (Post Tax) (%) | -0.05 | -0.95 | -0.01 | 2.51 | 1.55 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 306.54 | 206.19 | 218.00 | 219.35 | 122.56 |
| EV / Net Operating Revenue (X) | 2.92 | 1.60 | 1.75 | 1.65 | 1.15 |
| EV / EBITDA (X) | 264.63 | -54.80 | 139.42 | 20.24 | 22.63 |
| MarketCap / Net Operating Revenue (X) | 2.51 | 1.20 | 1.42 | 1.35 | 0.87 |
| Price / BV (X) | 797.28 | 28.15 | 11.95 | 9.74 | 6.98 |
| Price / Net Operating Revenue (X) | 2.51 | 1.20 | 1.42 | 1.35 | 0.87 |
| EarningsYield | -0.02 | -0.06 | -0.02 | 0.02 | 0.01 |
